Anzeige
Mehr »
Login
Mittwoch, 28.09.2022 Börsentäglich über 12.000 News von 675 internationalen Medien
Wo es gerade richtig läuft!? – Wo kann man jetzt Geld verdienen?
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

Aktuelle News von PMLiVE

  • 24 h
  • letzte 200 News
ZeitAktuelle Nachrichten
08.08.UK government's 'science superpower' ambitions to fail without clear plan, Lords committee warns
05.08.Amgen acquires ChemoCentryx in $3.7bn cash deal
05.08.Gilead Sciences set to acquire MiroBio in deal worth over $400m
05.08.NHS England to roll out continuous glucose monitors to all those with type 1 diabetes
05.08.Sanofi and Innovent Biologics to develop oncology drugs for patients in China
05.08.WHO launches funding appeal for greater Horn of Africa prompted by food crisis
04.08.The patient voice - the value of patient-reported outcomes in HTA
04.08.AstraZeneca and MSD's breast cancer drug Lynparza receives EC approval
04.08.Biogen and Eisai share latest lecanemab results for the treatment of Alzheimer's disease
04.08.Eli Lilly to make bebtelovimab commercially available to US states from August
04.08.AbbVie's Allergan reaches proposed $2.37bn agreement to settle US opioid lawsuits
04.08.FDA approves Coherus' Cimerli as biosimilar interchangeable with Lucentis for all five indications
03.08.Innovation through collaboration - the importance of partnerships
03.08.WHO, UNICEF and UNAIDS launch global alliance to end AIDS in children by 2030
03.08.Janssen's Stelara approved by FDA for psoriatic arthritis in paediatric patients
03.08.Alzheimer's Research UK calls for government action to address inequalities in dementia risk
03.08.Arcutis receives FDA approval for steroid-free plaque psoriasis treatment
03.08.Boehringer Ingelheim and QUANTRO Therapeutics partner to develop drug candidates
02.08.'Who moved my cheese?'
02.08.Achieving communication excellence by targeting the right channel at the right time
02.08.Regeneron terminates four clinical trials of its COVID-19 antibody cocktail REGEN-COV
02.08.Roche's Tecentriq demonstrates positive phase 3 results as a subcutaneous injection
02.08.AstraZeneca and Innate Pharma to end study on immuno-oncology drug monalizumab
01.08.Gilead announces positive Biktarvy data for HIV and hepatitis B
01.08.GSK's ViiV and Medicines Patent Pool agree deal for HIV prevention